Gerard Scimeca – Chairman, CASE June 24, 2021 Reasonable Americans agree that when people can’t afford the basic necessities of […]
June 21, 2021 This past year has been a difficult one for American patients. Due to COVID-19 and the financial […]
June 17, 2021 Far-left broadband bill is Big Tech welfare that invites corruption, stifles competition, and tramples on state sovereignty […]
President Biden has continued his push to include the PRO Act as a part of his administration’s signature $2.3 trillion […]
June 8, 2021 The top trade officials from the major industrialized nations met recently to discuss a nettlesome and costly […]
Matthew Kandrach – President, CASE June 2, 2021 America’s energy future will be shaped to a significant degree by two […]
Matthew Kandrach – President, CASE June 2, 2021 Pennsylvania lawmakers, including several from central and western PA, will play a […]
Global demand for electricity is exploding, and the future of economic growth and development for all nations will stand or […]
May 24, 2021 Right now, the Biden administration is in the middle of selling its $2 trillion-plus infrastructure package, $1.8 […]
Gerard Scimeca – co-founder, CASE May 10, 2021 It has been over two months since Mat Ishbia’s Facebook Live […]
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/